Risk Factors of Peptic Ulcer in 4943 Inpatients
- 1 April 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 42 (4) , 373-380
Abstract
Over the past few years, major changes have taken place in the treatment of gastroduodenal peptic ulcer. To evaluate risk factors associated with the incidence of peptic ulcer in inpatients. From 2001 to 2004, the number of prescriptions of H2-antagonists and proton pump inhibitors (PPIs) in each department of Verona University Hospital was monitored. Over the same period we prospectively recorded the number of upper endoscopies per department for inpatients with a diagnosis of peptic ulcer. We analyzed 4943 inpatients. A significantly decreasing trend in H(2)-antagonist prescriptions (r=-0,88; P<0.001) and an increasing trend in PPI prescriptions (r=0.97; P<0.001) were observed. The endoscopic incidence of duodenal ulcers decreased linearly from 2001 to 2004 as follows: 6.5% (94/1439) in 2001, 5.6% (82/1473) in 2002, 4.5% (63/1411) in 2003, and 3.1% (22/702) (P<0.001) in 2004. Gastric ulcer incidence, sex, age, indication for endoscopy, use of nonsteroidal anti-inflammatory drugs (NSAIDs), presence of Helicobacter pylori (32%), and smoking and drinking habits showed no significant changes over the study period. Considering time-dependent variables, multivariate regression analysis identified only PPI use and NSAID use as factors predictive of duodenal ulcer but not of gastric ulcer. In inpatients, PPIs are associated with a reduced risk of duodenal ulcer, whereas NSAIDs are associated with an increased risk. Gastric ulcer was not associated with any increased or degreased risk with the 2 above-mentioned variables.Keywords
This publication has 25 references indexed in Scilit:
- Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinationsGut, 2006
- Peptic Ulcer Disease in a General Adult PopulationAmerican Journal of Epidemiology, 2006
- Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician‐referred uninvestigated dyspeptic patients in Hong KongAlimentary Pharmacology & Therapeutics, 2005
- Proton pump inhibitors: a survey of prescribing in an Irish general hospitalInternational Journal Of Clinical Practice, 2004
- Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirinDigestive and Liver Disease, 2004
- Non‐steroidal anti‐inflammatory drugs: who should receive prophylaxis?Alimentary Pharmacology & Therapeutics, 2004
- A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adultsJournal of Clinical Epidemiology, 2004
- Helicobacter pylori and perforated peptic ulcer. Prevalence of the infection and role of non-steroidal anti-inflammatory drugsDigestive and Liver Disease, 2004
- Helicobacter pylori , Non-steroidal Anti-inflammatory Drugs and Smoking in Risk Pattern of Gastroduodenal UlcersScandinavian Journal of Gastroenterology, 2003
- Economic Evaluation of Celecoxib, a New Cyclo-Oxygenase 2 Specific Inhibitor, in SwitzerlandPharmacoEconomics, 2001